{"Symbol": "ACXP", "AssetType": "Common Stock", "Name": "Acurx Pharmaceuticals LLC", "Description": "Acurx Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company is headquartered in Staten Island, New York.", "CIK": "1736243", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "259 LIBERTY AVENUE, STATEN ISLAND, NY, UNITED STATES, 10305", "OfficialSite": "https://www.acurxpharma.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "5017000", "EBITDA": "None", "PERatio": "None", "PEGRatio": "None", "BookValue": "2.02", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-8.18", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-0.956", "ReturnOnEquityTTM": "-2.911", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "-8.18", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "61.7", "AnalystRatingStrongBuy": "-", "AnalystRatingBuy": "-", "AnalystRatingHold": "-", "AnalystRatingSell": "-", "AnalystRatingStrongSell": "-", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "-", "PriceToBookRatio": "1.379", "EVToRevenue": "-", "EVToEBITDA": "-3.54", "Beta": "-1.218", "52WeekHigh": "21", "52WeekLow": "1.89", "50DayMovingAverage": "2.915", "200DayMovingAverage": "5.6", "SharesOutstanding": "2546700", "SharesFloat": "1971100", "PercentInsiders": "5.050", "PercentInstitutions": "7.709", "DividendDate": "None", "ExDividendDate": "None"}